These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12928207)

  • 1. Ventricular reshaping with devices.
    Schenk S; Reichenspurner H
    Heart Surg Forum; 2003; 6(4):237-43. PubMed ID: 12928207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial.
    Acker MA; Bolling S; Shemin R; Kirklin J; Oh JK; Mann DL; Jessup M; Sabbah HN; Starling RC; Kubo SH;
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):568-77, 577.e1-4. PubMed ID: 16935112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac support devices.
    Rodger M; McRae ME; Jaffer M; Bailey B; Del Signore S
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):169-80. PubMed ID: 20002342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
    Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
    J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery Insight: surgical methods to reverse left ventricular remodeling.
    De Bonis M; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):507-13. PubMed ID: 16932768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular restoration devices.
    Oliveira GH; Al-Kindi SG; Bezerra HG; Costa MA
    J Cardiovasc Transl Res; 2014 Apr; 7(3):282-91. PubMed ID: 24574107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery.
    Acker MA
    Semin Thorac Cardiovasc Surg; 2005; 17(4):361-3. PubMed ID: 16428044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling.
    Pitsis AA; Visouli AN; Ninios V; Bougioukas G; Filippatos G; Kremastinos D; Burkhoff D; Long JW
    Artif Organs; 2008 Sep; 32(9):730-5. PubMed ID: 18684205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First clinical experience with the Incor left ventricular assist device.
    Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
    J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid pacing for the off-pump insertion of the Jarvik left ventricular assist device.
    Centofanti P; La Torre M; Attisani M; Sansone F; Rinaldi M
    Ann Thorac Surg; 2011 Oct; 92(4):1536-8. PubMed ID: 21958820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.
    Mann DL; Acker MA; Jessup M; Sabbah HN; Starling RC; Kubo SH;
    Ann Thorac Surg; 2007 Oct; 84(4):1226-35. PubMed ID: 17888974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure.
    Rastogi S; Gupta RC; Mishra S; Morita H; Tanhehco EJ; Sabbah HN
    J Heart Lung Transplant; 2005 Oct; 24(10):1619-25. PubMed ID: 16210139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
    Morley D; Litwak K; Ferber P; Spence P; Dowling R; Meyns B; Griffith B; Burkhoff D
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):21-8. PubMed ID: 17198776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology of left ventricular dyssynchrony and resynchronization.
    Spragg DD; Kass DA
    Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.